Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.
暂无分享,去创建一个
[1] Thomas Beyer,et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] S S Gambhir,et al. A tabulated summary of the FDG PET literature. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Anne Bol,et al. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] Yoshimi Anzai,et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. , 2005, International journal of radiation oncology, biology, physics.
[5] P. Price,et al. The Role of PET in Target Localization for Radiotherapy Treatment Planning , 2008, Oncology Research and Treatment.
[6] K Schnabel,et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.
[7] Randall K Ten Haken,et al. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. , 2009, International journal of radiation oncology, biology, physics.
[8] B. Cheson,et al. Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.
[9] Julie R. Gralow,et al. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] W. Enghardt,et al. In-beam PET at high-energy photon beams: a feasibility study , 2006, Physics in medicine and biology.
[11] J. Mortensen,et al. The Future in Diagnosis and Staging of Lung Cancer: Positron Emission Tomography , 2006, Respiration.
[12] Branislav Jeremic,et al. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[13] Pedro Andreo,et al. On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams , 2009, Physics in medicine and biology.
[14] Terry Jones,et al. The role of positron emission tomography within the spectrum of medical imaging , 1996, European Journal of Nuclear Medicine.
[15] H. Bartelink,et al. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. , 2004, International journal of radiation oncology, biology, physics.
[16] K. Herholz,et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.
[17] Anders Brahme,et al. Recent advances in light ion radiation therapy. , 2004, International Journal of Radiation Oncology, Biology, Physics.
[18] Dean Billheimer,et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] Philippe Lambin,et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. , 2006, Cancer treatment reviews.
[20] P. Bossuyt,et al. Limited additional value of positron emission tomography in staging oesophageal cancer , 2007, The British journal of surgery.
[21] Jean-François Daisne,et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.
[22] Wolfgang A Weber,et al. Use of PET for monitoring cancer therapy and for predicting outcome. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] Keiichi Nakagawa,et al. The development and clinical use of a beam ON-LINE PET system mounted on a rotating gantry port in proton therapy. , 2008, International journal of radiation oncology, biology, physics.
[24] S. Kalnicki,et al. Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume. , 2008, Seminars in nuclear medicine.
[25] Jeffrey D Bradley,et al. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] M. Graham,et al. Comparison of simplified quantitative analyses of FDG uptake. , 2000, Nuclear medicine and biology.
[27] K Parodi,et al. In-beam PET measurement of 7Li3+ irradiation induced beta+-activity. , 2008, Physics in medicine and biology.
[28] H. Amthauer,et al. Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. , 2008, Blood.
[29] S. Webb,et al. Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] Curtis B Caldwell,et al. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. , 2003, International journal of radiation oncology, biology, physics.
[31] Tove Grönroos,et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. , 2004, International Journal of Radiation Oncology, Biology, Physics.
[32] S. Reske,et al. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] Thomas Beyer,et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. , 2003, Radiology.
[34] T. A. Smith,et al. FDG uptake, tumour characteristics and response to therapy: A review , 1998, Nuclear medicine communications.
[35] Pek-Lan Khong,et al. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. , 2009, Radiology.
[36] J. Plukker,et al. Role of positron emission tomography in the (re-)staging of oesophageal cancer , 2006, Scandinavian journal of gastroenterology. Supplement.
[37] P. Lambin,et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients , 2007 .
[38] Johannes A Langendijk,et al. Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] Jinming Yu,et al. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.
[40] J. Buatti,et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. , 2009, International journal of radiation oncology, biology, physics.
[41] Katia Parodi,et al. In-beam PET measurements of β+ radioactivity induced by proton beams , 2002 .
[42] F MURRAY,et al. Diagnosis and treatment of lung cancer. , 1955, Geriatrics.
[43] John L. Humm,et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] Thomas Beyer,et al. Dual-modality PET/CT instrumentation-today and tomorrow. , 2010, European journal of radiology.
[45] Morand Piert,et al. Experience of PET for target localisation in radiation oncology , 2005 .
[46] F. Grünwald,et al. Die Positronenemissionstomographie zur präoperativen Lymphknotendiagnostik bei Ösophaguskarzinom , 2003, Der Chirurg.
[47] J. Buatti,et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. , 2005, International journal of radiation oncology, biology, physics.
[48] Dag Rune Olsen,et al. Strategies for biologic image-guided dose escalation: a review. , 2009, International journal of radiation oncology, biology, physics.
[49] N Cascinelli,et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[50] H. Minn,et al. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[51] R Jeraj,et al. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study , 2007, Physics in medicine and biology.
[52] D. Visvikis,et al. The role of PET/CT scanning in radiotherapy planning. , 2006, The British journal of radiology.
[53] N. Moriyama,et al. Evaluation of the risk of radiation exposure from new 18FDG PET/CT plans versus conventional X-ray plans in patients with pediatric cancers , 2010, Annals of nuclear medicine.
[54] Gig Mageras,et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[55] Ellen Yorke,et al. 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy* , 2009, Journal of Nuclear Medicine.
[56] Norbert Avril,et al. Relevance of Positron Emission Tomography (PET) in Oncology , 1999, Strahlentherapie und Onkologie.
[57] Ursula Nestle,et al. Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.
[58] S. Nehmeh,et al. Respiratory motion in positron emission tomography/computed tomography: a review. , 2008, Seminars in nuclear medicine.
[59] K Parodi,et al. In-beam PET monitoring of mono-energetic 16O and 12C beams: experiments and FLUKA simulations for homogeneous targets , 2009, Physics in medicine and biology.
[60] Aswin L Hoffmann,et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] Branislav Jeremic,et al. Positron Emission Tomography for Radiation Treatment Planning , 2005, Strahlentherapie und Onkologie.
[62] Alfred A Bartolucci,et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. , 2004, The Annals of thoracic surgery.
[63] T. Jones. The imaging science of positron emission tomography , 1996, European Journal of Nuclear Medicine.
[64] P. Choyke,et al. Prostate specific membrane antigen- a target for imaging and therapy with radionuclides. , 2010, Discovery medicine.
[65] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[66] P. Price,et al. Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue , 2009, Molecular Cancer Therapeutics.
[67] A. Riegel,et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. , 2005, International journal of radiation oncology, biology, physics.
[68] Tomio Inoue,et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[69] David Binns,et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. , 2004, International journal of radiation oncology, biology, physics.
[70] S Leide-Svegborn,et al. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. , 2010, Radiation protection dosimetry.
[71] J. Plukker,et al. Staging in oesophageal cancer. , 2006, Best practice & research. Clinical gastroenterology.
[72] E Yorke,et al. Four-dimensional (4D) PET/CT imaging of the thorax. , 2004, Medical physics.
[73] L. Kong,et al. [Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients]. , 2009, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[74] Aswin L Hoffmann,et al. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[75] Karin Haustermans,et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[76] P. Jarritt,et al. Personnel radiation dose considerations in the use of an integrated PET-CT scanner for radiotherapy treatment planning. , 2009, The British journal of radiology.
[77] Yoshimi Anzai,et al. FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation , 2005, Head & neck.
[78] Rita Engenhart-Cabillic,et al. Ion beam radiobiology and cancer: time to update ourselves. , 2009, Biochimica et biophysica acta.
[79] Wim J. G. Oyen,et al. Methodological considerations in quantification of oncological FDG PET studies , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[80] Johan Bussink,et al. Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET , 2010, Journal of Nuclear Medicine.
[81] Katia Parodi,et al. In-beam PET measurements of biological half-lives of 12C irradiation induced β+-activity , 2008, Acta oncologica.